0001567619-19-021570.txt : 20191114 0001567619-19-021570.hdr.sgml : 20191114 20191114161431 ACCESSION NUMBER: 0001567619-19-021570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191112 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLER RICHARD A MD CENTRAL INDEX KEY: 0001031847 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 191220326 MAIL ADDRESS: STREET 1: PHARMACYCLICS INC STREET 2: 995 E ARQUES AVE CITY: SUNNYVALE STATE: CA ZIP: 94085-4521 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc1.xml FORM 4 X0306 4 2019-11-12 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001031847 MILLER RICHARD A MD CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 1 1 0 0 President and CEO Common Stock 2019-11-12 4 P 0 272 2.90 A 1163779 I By Trust Common Stock 2019-11-13 4 P 0 14736 3.0022 A 1178515 I By Trust A portion of these shares is subject to a right of repurchase held by the Issuer. These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $2.9543 to $3.0194 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller 2019-11-14